Expanding commercial partnerships with large national hospital networks, regional outpatient care networks, and specialty clinics to broaden the distribution of the EsoGuard test.

Expected impact: Lays the groundwork for scalable, long-term test volume growth and increased market penetration.

Completing additional clinical studies and publishing peer-reviewed real-world evidence to support expanded labeling and guidelines recognition (such as NCCN) for EsoGuard/EsoCheck.

Expected impact: Strengthens the clinical utility case for payers and providers, facilitating broader insurance coverage and clinical adoption.

Implementing operational efficiency measures to reduce redundant costs, optimize laboratory workflows, and improve gross margin profiles over time.

Expected impact: Aims to narrow operating losses and transition the company toward a sustainable path to profitability.